Terms: = Brain cancer AND CARS, P49589, 833, ENSG00000110619 AND Treatment
52 results:
1. CD19 CAR-expressing iPSC-derived NK cells effectively enhance migration and cytotoxicity into glioblastoma by targeting to the pericytes in tumor microenvironment.
Kong D; Kwon D; Moon B; Kim DH; Kim MJ; Choi J; Kang KS
Biomed Pharmacother; 2024 May; 174():116436. PubMed ID: 38508081
[TBL] [Abstract] [Full Text] [Related]
2. Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort study and meta-analyses.
Kuan AS; Chiang CL; Wu HM; Yang HC; Chen CJ; Lin CJ; Guo WY; Pan DH; Chung WY; Lee CC
J Neurooncol; 2023 Sep; 164(3):729-739. PubMed ID: 37721662
[TBL] [Abstract] [Full Text] [Related]
3. IL13Rα2-targeted third-generation CAR-T cells with CD28 transmembrane domain mediate the best anti-glioblastoma efficacy.
Gu A; Bai Y; Zhang C; Xu C; An Z; Zhang Y; Zhong SH; Hu Y; Zhong X
Cancer Immunol Immunother; 2023 Jul; 72(7):2393-2403. PubMed ID: 36991262
[TBL] [Abstract] [Full Text] [Related]
4. Raman Spectroscopy as a Tool to Study the Pathophysiology of brain Diseases.
Terrones O; Olazar-Intxausti J; Anso I; Lorizate M; Nieto-Garai JA; Contreras FX
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768712
[TBL] [Abstract] [Full Text] [Related]
5. Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast cancer brain Metastases.
Jenkins S; Zhang W; Steinberg SM; Nousome D; Houston N; Wu X; Armstrong TS; Burton E; Smart DD; Shah R; Peer CJ; Mozarsky B; Arisa O; Figg WD; Mendoza TR; Vera E; Brastianos P; Carter S; Gilbert MR; Anders CK; Connolly RM; Tweed C; Smith KL; Khan I; Lipkowitz S; Steeg PS; Zimmer AS
Clin Cancer Res; 2023 Apr; 29(8):1450-1459. PubMed ID: 36705597
[TBL] [Abstract] [Full Text] [Related]
6. Machine learning approaches for prediction of early death among lung cancer patients with bone metastases using routine clinical characteristics: An analysis of 19,887 patients.
Cui Y; Shi X; Wang S; Qin Y; Wang B; Che X; Lei M
Front Public Health; 2022; 10():1019168. PubMed ID: 36276398
[TBL] [Abstract] [Full Text] [Related]
7. Radiomic study on preoperative multi-modal magnetic resonance images identifies IDH-mutant TERT promoter-mutant gliomas.
Wang H; Zhang S; Xing X; Yue Q; Feng W; Chen S; Zhang J; Xie D; Chen N; Liu Y
Cancer Med; 2023 Feb; 12(3):2524-2537. PubMed ID: 36176070
[TBL] [Abstract] [Full Text] [Related]
8. Chimeric Antigen Receptor (CAR) T Cell Therapy for Glioblastoma.
Verma A; Rafiq S
Cancer Treat Res; 2022; 183():161-184. PubMed ID: 35551659
[TBL] [Abstract] [Full Text] [Related]
9. Genetically Modified Cellular Therapies for Malignant Gliomas.
Kilian M; Bunse T; Wick W; Platten M; Bunse L
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884607
[TBL] [Abstract] [Full Text] [Related]
10. Generation of an NFκB-Driven Alpharetroviral "All-in-One" Vector Construct as a Potent Tool for CAR NK Cell Therapy.
Rudek LS; Zimmermann K; Galla M; Meyer J; Kuehle J; Stamopoulou A; Brand D; Sandalcioglu IE; Neyazi B; Moritz T; Rossig C; Altvater B; Falk CS; Abken H; Morgan MA; Schambach A
Front Immunol; 2021; 12():751138. PubMed ID: 34804035
[TBL] [Abstract] [Full Text] [Related]
11. 3D Deep Learning Model for the Pretreatment Evaluation of treatment Response in Esophageal Carcinoma: A Prospective Study (ChiCTR2000039279).
Li X; Gao H; Zhu J; Huang Y; Zhu Y; Huang W; Li Z; Sun K; Liu Z; Tian J; Li B
Int J Radiat Oncol Biol Phys; 2021 Nov; 111(4):926-935. PubMed ID: 34229050
[TBL] [Abstract] [Full Text] [Related]
12. Physiological MRI of microvascular architecture, neovascularization activity, and oxygen metabolism facilitate early recurrence detection in patients with IDH-mutant WHO grade 3 glioma.
Stadlbauer A; Heinz G; Oberndorfer S; Zimmermann M; Kinfe TM; Buchfelder M; Dörfler A; Kremenevski N; Marhold F
Neuroradiology; 2022 Feb; 64(2):265-277. PubMed ID: 34115146
[TBL] [Abstract] [Full Text] [Related]
13. [CAR-T Cells in solid tumours: present and future].
Ben Aïssa A; Niculescu MV; Migliorini D
Rev Med Suisse; 2021 May; 17(739):985-993. PubMed ID: 34009758
[TBL] [Abstract] [Full Text] [Related]
14. Chimeric Antigen Receptor T Cells for Glioblastoma: Current Concepts, Challenges, and Future Perspectives.
Karschnia P; Teske N; Thon N; Subklewe M; Tonn JC; Dietrich J; von Baumgarten L
Neurology; 2021 Aug; 97(5):218-230. PubMed ID: 33986138
[TBL] [Abstract] [Full Text] [Related]
15. Chimeric antigen receptor T-cell therapy in glioblastoma: charging the T cells to fight.
Land CA; Musich PR; Haydar D; Krenciute G; Xie Q
J Transl Med; 2020 Nov; 18(1):428. PubMed ID: 33176788
[TBL] [Abstract] [Full Text] [Related]
16. Ramucirumab or placebo plus erlotinib in EGFR-mutated, metastatic non-small-cell lung cancer: East Asian subset of RELAY.
Nishio M; Seto T; Reck M; Garon EB; Chiu CH; Yoh K; Imamura F; Park K; Shih JY; Visseren-Grul C; Frimodt-Moller B; Zimmermann A; Homma G; Enatsu S; Nakagawa K;
Cancer Sci; 2020 Dec; 111(12):4510-4525. PubMed ID: 32954593
[TBL] [Abstract] [Full Text] [Related]
17. Analysis of 7-tesla diffusion-weighted imaging in the prediction of pituitary macroadenoma consistency.
Rutland JW; Loewenstern J; Ranti D; Tsankova NM; Bellaire CP; Bederson JB; Delman BN; Shrivastava RK; Balchandani P
J Neurosurg; 2020 Feb; 134(3):771-779. PubMed ID: 32109870
[TBL] [Abstract] [Full Text] [Related]
18. CAR-Engineered NK Cells for the treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for cancer Immunotherapy.
Burger MC; Zhang C; Harter PN; Romanski A; Strassheimer F; Senft C; Tonn T; Steinbach JP; Wels WS
Front Immunol; 2019; 10():2683. PubMed ID: 31798595
[TBL] [Abstract] [Full Text] [Related]
19. CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors.
Jin L; Tao H; Karachi A; Long Y; Hou AY; Na M; Dyson KA; Grippin AJ; Deleyrolle LP; Zhang W; Rajon DA; Wang QJ; Yang JC; Kresak JL; Sayour EJ; Rahman M; Bova FJ; Lin Z; Mitchell DA; Huang J
Nat Commun; 2019 Sep; 10(1):4016. PubMed ID: 31488817
[TBL] [Abstract] [Full Text] [Related]
20. Beyond TCR Signaling: Emerging Functions of Lck in cancer and Immunotherapy.
Bommhardt U; Schraven B; Simeoni L
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31315298
[TBL] [Abstract] [Full Text] [Related]
[Next]
